Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroBo Pharmaceuticals, Inc.

2.36
0.0000
Volume:- -
Turnover:31.15K
Market Cap:20.33M
PE:-0.55
High:2.36
Open:2.36
Low:2.36
Close:2.36
Loading ...
Nov 04, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 03, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 03, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 24, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 24, 2022

Major Issues Report

8-K - Current report
Oct 24, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 16, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Sep 15, 2022

Major Issues Report

8-K - Current report
Sep 14, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]